Disease free survival (n=26) | Overall survival (n=27) | |||||
HR | 95% CI | P value | HR | 95% CI | P value | |
Radiotherapy | 0.22 | (0.05 to 0.91) | 0.036 | 0.13 | (0.13 to 0.63) | 0.012 |
Chemotherapy | 0.8 | (0.22 to 2.88) | 0.73 | 0.13 | (0.13 to 0.86) | 0.034 |
ECOG-PS 1–2 (reference=0) | NE | 23.8 | (23.8 to 169.2) | 0.002 | ||
FIGO stage III (reference=I–II) | NE | 7.8 | (7.8 to 33.5) | 0.006 | ||
Vascular invasion | 6.3 | (1.5 to 27.7) | 0.014 | NE |
ECOG-PS, Eastern Cooperative Oncology Group-performance status; FIGO, International Federation of Gynecology and Obstetrics; HR, hazard ratio; NE, not entered in the model.